https://www.selleckchem.com/pr....oducts/alkbh5-inhibi
prioritized, especially in individuals at risk for developing de novo BP.Venous thromboembolism (VTE) is common in cancer patients. While in the general population blood type non-O is associated with increased VTE risk, the impact of ABO blood type on risk of cancer-associated VTE has not been clarified. To determine the influence of ABO blood type on cancer-associated VTE risk, we conducted an analysis within the Vienna Cancer and Thrombosis Study (CATS), a prospective cohort study including patients with newly diagnosed or
Like
Comment
Share
